Table: Ono Pharm -Q1 group results (IFRS)

ONO PHARMACEUTICAL

31/07/2023 04:00

Jul 31 (Reuters)- 
              Ono Pharmaceutical Co Ltd 
              CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified) 
                   3 months ended      3 months ended       Year to 
                  Jun 30, 2023        Jun 30, 2022     Mar 31, 2024 
                     LATEST             YEAR-AGO          COMPANY   
                     RESULTS             RESULT          FORECAST   
  Sales              120.02              106.72           475.00    
                   (+12.5 pct)         (+22.2 pct)      (+6.2 pct)  
  Operating           41.35               38.16           153.00    
                   (+8.3 pct)          (+28.1 pct)      (+7.8 pct)  
  Pretax              42.38               39.04           154.00    
                   (+8.5 pct)          (+26.7 pct)      (+7.3 pct)  
  Net                 31.82               29.48           115.00    
                   (+7.9 pct)          (+22.4 pct)      (+2.0 pct)  
  EPS Basic         65.16 yen           60.37 yen       235.49 yen  
  EPS Diluted       65.15 yen           60.36 yen                   
  Ann Div                               70.00 yen        80.00 yen  
  -Q2 Div                               33.00 yen        40.00 yen  
  -Q4 Div                               37.00 yen        40.00 yen  
 
  NOTE - Ono Pharmaceutical Co Ltd. 
  (Figures are reported based on international accounting rules (IFRS).) 
  If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half 
  dividend and Q4 to the second-half dividend announced before a new corporate law in 
  2006 allowed companies to pay and report dividends on a quarterly basis.
  *Net - represents Net profit attributable to owners of the parent company. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4528.T